0001209191-20-038048.txt : 20200619
0001209191-20-038048.hdr.sgml : 20200619
20200619182034
ACCESSION NUMBER: 0001209191-20-038048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200619
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klibanski Anne
CENTRAL INDEX KEY: 0001741577
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 20976840
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 10 POST OFFICE SQUARE, SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-19
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001741577
Klibanski Anne
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 1000
BOSTON
MA
02109
1
0
0
0
Stock Option (right to buy)
27.89
2020-06-19
4
A
0
8000
0.00
A
2030-06-18
Common Stock
8000
8000
D
This option will vest and become exercisable in full on the earlier of (i) June 19, 2021 or (ii) the day prior to the issuer's 2021 annual meeting of stockholders, subject to the director's continued service on the issuer's board of directors on the vesting date.
/s/ Jason Duncan, Attorney-in-fact
2020-06-19